Drugs / ALLO-ASCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03113747 | Mar 2015 → Dec 2018 | — | A.A. Partners, LLC | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALLO-ASCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03113747 ↗ |
| Modality | Cell therapy | “Cryopreserved cell suspension of early passages of cultured allogeneic MSCs isolated from SVF obtained from lipoaspirate” NCT03113747 ↗ |